Increase of dengue cases comes in cycles
Posted by: Isa Lorenzo | September 20, 2006 at 10:10 pm
Filed under: In the News, Public Health
THE good news is that the 15,635 dengue cases recorded from January 1 to September 13 of this year have decreased by 40.7 percent compared to the same period last year.
But this doesn’t necessarily mean that we’re doing a better job when it comes to fighting dengue, according to Dr. Eric Tayag, director of the National Epidemiology Center (NEC).
In the Philippines, dengue occurs in a two to three year cycle, meaning that the incidence of dengue cases peaks according to this interval.
The last peak occurred during 2005, thus following the cycle, this year’s number of dengue cases should be half of last year’s figure, says Tayag. (see the cycle here)
Thirty-three thousand cases of dengue were recorded last year, but more than 15,000 cases have already been tallied this year.
“Ang hirap ng sustainability ng dengue control measures, lalo na nakasalalay siya sa (It’s hard to sustain dengue control measures, especially when it depends on) source reduction, o elimination ng mosquito breeding sites,” says Tayag.
“The behavior of looking for mosquito breeding sites and destroying them should become a habit,” he adds, yet this takes a long time because people forget what they have to do.
Relatives and acquaintances of dengue victims and residents of areas where dengue cases have been reported actively search for and destroy mosquito breeding sites. Yet those who live in areas where no dengue has been reported do nothing, according to Tayag.
The NEC has come up with four simple steps, known as the 4 S’s, for preventing dengue:
- Search and destroy all mosquito breeding sites, wherever clean, stagnant water may accumulate. This includes artificial containers such as old tires and drums.
- Self-protection: wear protective clothing such as long-sleeved blouses and pants, use insect repellent on exposed areas.
- Seek early consultation. Symptoms include high fever, cough, vomiting, and abdominal pain. Dengue is difficult to diagnose because many of its symptoms are common ailments.
- Say no to indiscriminate fogging. Fogging eliminates adult mosquitoes, but not their eggs or larvae. Thus fogging should only be done in places where there are epidemics, where large populations of adult mosquitoes have been proven to exist.
Thailand is working on a dengue vaccine, but it will not be available commercially for at least five years.
NEC data shows that dengue cases peak during August, when rain provides more breeding grounds for mosquitoes. This year’s hotspots include the province of Rizal, as well as the barangays of Batasan Hills, Payatas and Tatalon in Quezon City. The National Capital Region is among the top three regions with the highest number of recorded dengue cases this year. One of the reasons could be the proliferation of construction sites, which provide many places for stagnant water to collect in.
However, official reports of dengue cases have been perceived to be inaccurate, according to a 2003 study for the International Vaccine Institute led by Denise de Roeck. The study focused on the views of policymakers on dengue fever in four Southeast Asian countries, including the Philippines. Under-reporting and over-reporting were believed to occur, due to the lack of laboratory confirmation and the difficulty in diagnosing dengue.
There was also a lack of distinction between dengue and dengue hemmorhagic fever (DHF) cases. In once instance, the re-examination of suspected DHF patients Cagayan revealed that only 10 percent actually had DHF.
Policymakers may debate on the veracity of official figures, yet dengue remains the most important tropical infectious disease after malaria, according to the Centers for Disease Control and Prevention.
The first dengue outbreak in the Philippines occurred in 1954, and since then, according to a 1998 report by M. N. Chua and F. Galsim-Hernandez, there have been epidemics almost every year.
feel free to leave a comment
You must be logged in to post a comment.












3 people have left comments
Thailand’s Mahidol University is doing vaccine research and so are we. Dr. Ma. Rosario Capeding of our Research Institute for Tropical Medicine (RITM) in Alabang leads the Dengue Research Program.
ChimeriVax-Dengue is being developed and being tried worldwide. This site discussed About Dengue fever and About ChimeriVax-Dengue…
Sometimes called “breakbone fever” because of the pain associated with the disease, dengue fever is a flu-like illness characterised by high fever, severe headaches, joint and muscle pain, nausea and vomiting. As the fever progresses, a rash develops on the arms and legs, and may be associated with itching or peeling of the skin. The duration of the illness is, on average, 10 days but full recovery can take up to four weeks. A potentially fatal complication is dengue haemorrhagic fever (DHF). This is a more severe form of the disease and is recognised when the patient’s condition deteriorates after the first few days of the fever. Haemorrhagic manifestations occur such as bruising easily, bleeding from the nose or gums and internal haemorrhaging. This can led to circulatory failure, shock and, in some cases, death.
So, the milder Dengue Fever may complicate into the life-threatening Dengue Hemorrhagic Fever…that is where the distinction lie. Both conditions are one and the same as to their cause (and that is dengue virus harbored by day-biting mosquitoes).
What is difficult to assess are the probably numerous dengue cases not being reported as such due to their mild or non-alarming presentation. Because the illness is just like any ordinary viral illness wherein it comes and it goes, owing to its self-limited behavior, some (or a lot of) Dengue Fever cases may not really be included in the count. The bad thing about it is that first-time dengue cases may have mild condition but persons who have been bitten (dengue-laden mosquito bites) more than once may have bloody consequences.
There are four different dengue virus serotypes (DEN-1, DEN-2, DEN-3 and DEN-4) and while infection with one dengue serotype provides long-term immunity to that particular serotype, it provides only partial and transient protection against subsequent infection by the other three. More importantly, the WHO reports there is evidence that infection with a second serotype increases the risk of more serious disease resulting in dengue haemorrhagic fever.
So, maaaring mas kawawa pala ang mga na-dengue na dati…
Let’s hope and pray that the vaccine will come out in the near future because as it is NEC’s 4 S’s aren’t winning this year’s battle against dengue…might not an additional S should be included? Particularly for the DOH personnel to have common Sense of NOT downplaying the epidemic that is currently happening.
[...] THE loss of billions of pesos due to dengue could be halved by simply confirming an initial diagnosis. [...]
[...] Inside PCIJ reports about the four simple steps devised by the government to fight dengue. A dengue vaccine is also being developed in Thailand, but the public has to wait another five years. The unreliability of official dengue data was also underscored: “Official reports of dengue cases have been perceived to be inaccurate, according to a 2003 study for the International Vaccine Institute led by Denise de Roeck. The study focused on the views of policymakers on dengue fever in four Southeast Asian countries, including the Philippines. Under-reporting and over-reporting were believed to occur, due to the lack of laboratory confirmation and the difficulty in diagnosing dengue.” [...]